Thymidine phoshorylase expression in breast cancer: The prognostic significance and its association with other angiogenesis related proteins and extracellular matrix components

Histology and Histopathology

Volumn 23, Issue 2, 2008, Pages 187-196

  Ioachim, E ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Breast cancer; Cathepsin D; Extracellular matrix; Immunohistochemistry; Thymidine phosphorylase

Indexed keywords

CATHEPSIN D; SCLEROPROTEIN; THYMIDINE PHOSPHORYLASE; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; CELL NUCLEUS; CYTOPLASM; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; LUNG CARCINOMA; METABOLISM; MICROCIRCULATION; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VASCULARIZATION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CATHEPSIN D; CELL NUCLEUS; CYTOPLASM; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38449084417     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Anan K., Mitsuyama S., Tamae K., Suehara N., Nishihara K., Ogawa Y., Abe Y., Iwashita T. and Toyoshima S. (2003). Increased dihydropyrimidine dehydrogenase activity in breast cancer. J. Surg. Oncol. 82, 174-179.
2. Behrem S., Zarkovic K., Eskinja N. and Jonjic N. (2005). Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation. Pathol. Oncol. Res. 11, 229-235.
3. Berchem G., Glondu M., Gleizes M., Brouillet J.P., Vignon F., Garcia M. and Liaudet-Coopman E. (2002). Cathepsin-D affects multiple tumour progression steps in vivo: proliferation, angiogenesis and apoptosis. Ongogene 29, 5951-5955.
4. Elston C.W. and Ellis I.O. (1991). Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology 19, 403-410.
5. Engels K., Fox S.B., Whitehouse R.M., Gatter K.C. and Harris A.L. (1997). Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast. J. Pathol. 182, 414-420.
6. Feng X., Clark R.A., Galanakis D. and Tonnesen M.G. (1999). Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: stabilization of alphav/beta3mRNA by fibrin. J. Invest. Dermatol. 113, 913-919.
7. Fox S.B., Westwood M., Moghaddam A., Comley M., Turley H., Whitehouse R.M., Bicknell R., Gatter K.C. and Harris A.L. (1996). The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer 73, 275-280.
8. Fox S.B., Engels K., Compley M., Whitehouse R.M., Turley H., Gatter K.C. and Harris A.L. (1997). Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Ann. Oncol. 8, 271-275.
9. Fukuiwa T., Takebayashi Y., Akiba S., Matsuzaki T., Hanamure Y., Miyadera K., Yamada Y. and Akiyama S. (1999). Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics. Cancer 85, 960-969.
10. Gasparini G. (1996). Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studies. Eur. J. Cancer 32A, 2379-2385.
11. Gonzalez-Vela M.C., Garijo M.F., Fernandez F., Buelta L. and Val-Bernal J.F. (1999). Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma. Histopathology 34, 35-42.
12. Goto F., Goto K., Weindel K. and Folkman J. (1993). Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69, 508-517.
13. Hanahan D. and Folkman J. (1996). Patterns of emerging mechanisms of the angiogenic switch guring tumorigenesis. Cell 86, 353-364.
14. Haraguchi M., Miyadera K., Uemura K., Sumizawa T., Furukawa T., Yamada K., Akiyama S. and Yamada Y. (1994). Angiogenic activity of enzymes. Nature 17, 368, 198.
15. Ioachim E., Skopelitou A., Kamina S., Nonni A. and Agnantis N.J. (1998). p53 Protein Expression in Human Breast cancer: An Immunohistochemical Study Including Correlations with Steroid Receptors' Status, Proliferation Markers, Collagen Type IV, Laminin, C-erbB-2 Oncoprotein and Cathepsin D Expression. Breast 7, 42-48.
16. Ioachim E., Sebasti K., Demou A., Kontostolis M., Lolis D. and Agnantis N.J. (1999) Immunohistochemical localization of Metallothionein in human breast cancer in correlation with Cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation indices. Anticancer Res. 19, 2133-2139.
17. Ioachim E., Charchanti A., Briasoulis E., Karavasilis V., Tsanou H., Arvanitis D.L., Agnantis N.J. and Pavlidis N. (2002). Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: the prognostic value and role in tumour invasion and progression. Eur. J. Cancer 38, 2362-2370.
18. Imazano Y., Takebayashi Y., Nishiyama K., Akiba S., Miyadera K., Yamada Y, Akiyama S. and Ohi Y. (1997). Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J. Clin. Oncol. 15, 2570-2578.
19. Iozzo R.V. (1995). Tumour stroma as a regulator of neoplastic behavior. Lab. Invest. 73, 157-160.
20. Ishikawa F., Miyazono K., Hellman U., Drexler H., Wernstedt C., Hagiwara K., Usuki K., Takaku F., Risau W. and Heldin C.H. (1989). Identification of angiogenic activity and the cloning and expression of the platelet-derived endothelial cell growth factor. Nature 338, 557-562.
21. Kanzaki A., Takebayashi Y., Bando H., Eliason J.F., Watanabe S-I., Miyashita H., Fukumoto M., Toi M. and Uchida T. (2002). Expression of uridine and thymidine phosphorylase genes in human breast carcinoma. Int. J. Cancer 97, 631-635.
22. Kobayashi M., Okamoto K., Akimori T., Tochika N., Yoshimoto T., Okabayashi T., Sugimoto T. and Araki K. (2004). Localization of Thymidine phosphorylase in advanced gastric and colorectal cancer. J. Mol. Histol. 35, 69-74.
23. Kobayashi M., Sugimoto T., Okabayashi T., Okamoto K., Namikawa T., Tochika N., Moriki T. and Araki K. (2005). Localization of thymidine phosphorylase in breast cancer tissue. Med. Mol. Morphol. 38, 112-117.
24. Kubiak R., Miszczak-Zaborska E., Jesionek-Kupnicka D. and Greger J. (1999). The activity of thymidine phosphorylase correlates with tumor size and lymph nodes status in breast carcinoma. Z. Naturforsch. 54, 1096-1102.
25. Lehman N.L. (2002). Future potential of thymidylate synthase inhibitors in cancer therapy. Exp. Opin. Investig. Drugs 11, 1775-1787.
26. Lee A.H., Dublin E.A. and Bobrow L.G. (1999). Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast. J. Pathol. 187, 285-290.
27. Li H, Suo Z., Zhang Y., Risberg B., Karlsson M.G., Villman K. and Nesland J.M. (2004). The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas. Histol. Histopathol. 19, 129-136.
28. Madri J.A., Pratt B.M. and Tucker A.M. (1988). Phenotypic modulation of endothelial cell by transforming growth factor-b depends upon the composition of the extracellular matrix. J. Cell Biol. 106, 1375-1384.
29. Miyazono K., Okabe T., Urabe A., Takaku F. and Heldin C.H. (1987). Purification and properties of an endothelial growth factor from human platelets. J. Biol. Chem. 262, 4098-4103.
30. Miyazono K., Usuki K. and Heldin C.H. (1991). Platelet-derived endothelial cell growth factor. Prog. Growth Factor Res. 3, 207-217.
31. Mizutani Y., Wada H., Yoshida O., Fukushima M., Bonavida B., Kawauchi A. and Miki T. (2002). Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer. Oncol. Rep. 9, 289-292.
32. Moghaddam A., Zhang H.T., Fan T.P., Hu D.E. Lees V.C., Turley H., Fox S.B., Gatter K.C., Harris A.L. and Bicknell R. (1995). Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA 92, 988-1002.
33. Nagaoka H., Iino Y., Takei H. and Morishita Y. (1998). Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumour angiogenesis and prognosis in invasive breast cancer. Int. J. Oncol. 13, 449-454.
34. Poller D.N., Roberts E.C., Bell J.A., Elston C.W., Blamey R.W. and Ellis I.O. (1993) p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen recdeptor and c-erbB-2 protein. Hum. Pathol. 24, 463-468.
35. Relf M., LeJeune S., Scott P.A.E., Fox S., Smith K., Leek R., Moghaddam A. Whitehouse R., Bicknell R. and Harris A.L. (1997). Expression of the angiogenic factor vascular endothelial cell growth factor, acidic and basic fibroblast growth factors, tumour growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57, 963-969.
36. Rose M.G., Farrell M.P. and Schmitz J.C. (2002). Thymidylate synthase: a critical target for cancer chemotherapy. Clin. Colorectal Cancer 1, 220-229.
37. Ruoslahti E. and Yamaguchi Y. (1991). Proteoglycans as modulators of grwth factor activities. Cell 64, 867-869.
38. Seymour L. and Bezwoda W.R. (1994). Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer. Breast Cancer Res. Treat. 32, 229-233.
39. Soini Y., Vakkala M., Kahlos K., Paakko P. and Kimmula V. (2001). MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. J. Pathol. 195, 156-162.
40. Sutton A.B., Canfield A.E., Schor S.L., Grant M.E. and Schor A.M. (1991). The response of endothelial cells to TGFß-1 is dependent upon cell shape, proliferative state and the nature of the substratum. J. Cell Sci. 99, 777-787.
41. Swindle C.S., Tran K.T., Johnson T.D., Banerjee P., Mayer A.M., Griffith L. and Wells A. (2001). Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J. Cell Biol. 23, 459-468.
42. Takebayashi Y., Akiyama S., Akiba S., Yamada K., Miyadera K., Sumizawa T., Yamada Y., Murata F. and Aikou T. (1996a). Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinomas. J. Natl. Cancer Inst. 88, 1110-1117.
43. Takebayashi Y., Miyadera K., Akiyama S., Hokita S., Yamada K., Akiba S., Yamada Y., Sumizawa T. and Aikou T. (1996b). Expression of thymidine phosphorylase in human gastic carcinoma. Jpn. J. Cancer Res. 87, 288-295.
44. Takebayashi Y., Yamada K., Miyadera K., Sumizawa T., Furukawa T., Kinoshita F., Aoki D., Okumura H., Yamada Y., Akiyama S. and Aikou T. (1996). The activity and expression of thymidine phosphorylase in human solid tumors. Eur. J. Cancer 32, 1227-1232.
45. Takebayashi Y., Natsugoe S., Baba M., Akiba S., Fukumoto T., Miyadera K., Yamada Y., Takao S., Akiyama S. and Aikou T. (1999). Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer 85, 282-289.
46. Tanaka K., Hiraiwa N., Hashimoto H., Yamazaki Y. and Kusakabe M. (2004). Tenascin-C regulates angiogenesis in tumour through the regulation of vascular endothelial growth factor expression. Int. J. Cancer 108, 31-40
47. Teo N.B., Shoker B.S., Jarvis C., Sloane J.P. and Holcombe C. (2003). Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast. J. Clin. Pathol. 56, 919-923.
48. Tokes A.M., Hortovanyi E., Kulka J., Jackel M., kerenyi T., Kadar A. (1999). Tenascin expression and angiogenesis in breast cancers. Pathol. Res. Pract. 195, 821-828.
49. Toi M., Hoshina S., Taniguchi T., Yamamoto Y., Ishistuka H. and Tominaga T. (1995). Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer 64, 79-82.
50. Toi M., Gion M., Biganzoli E., Dittadi R., Boracchi P., Miceli R., Meli S., Mori K., Tominaga T. and Gasparinin G. (1997). Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications. Angiogenesis 1, 71-83.
51. Tominaga T., Toi M., Ohashi Y. and Abe O. (2002). Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients. Clin. Breast Cancer 3, 55-64.
52. Yang Q., Sakurai T., Shan L., Yoshimura G., Yu Z., Suzuma T., Tamaki T., Umemura T., Nakamura Y., Nakamura M., Utsunomiya H., Mori I. and Kakudo K. (2000). Thymidine phosphorylase expression correlates with tumor differentiation and Bcl-2 in invasive breast cancer. Breast Cancer 7, 210-214.
53. Yang Q., Barbareschi M., Mori I., Mauri F., Muscara M., Nakamura M., Nakamura Y., Yoshimura G., Sakurai T., Caffo O., Galligioni E., Dalla Palma P. and Kakudo K. (2002). Prognostic value of thymidine phosphorylase expression in breast carcinoma. Int. J. Cancer 97, 512-517.
54. Yonenaga F., Takasaki T., Ohi Y., Sagara Y., Akiba S., Yoshinaka H., Aikou T., Miyadera K., Akiyama S. and Yoshida H. (1998). The expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer. Pathol. Int. 48, 850-856.
55. Yoshimura A., Kuwazuru Y., Furukawa T., Yoshida H., Yamada K. and Akiyama S. (1990). Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes, and tumors. Biochim. Biophys. Acta 1034, 107-113.
56. Zagzag D., Shiff B., Jallo G.I., Greco M.A., Blanco C., Cohen H., Hukin J., Allen J.C. and Friedlander D.R. (2002). Tenascin-C promotes microvascular cell migration of focal adhesion kinase. 62, 1660-1668.
57. Zheng H., Tsuneyama K., Cheng C., Takahashi H., Cui Z., Murai Y., Nomoto K. and Takano Y. (2007). Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res. 27, 259-265.